Interestingly, the correlation between RAS84 expression and overall survival in pancreatic cancer, where 95% of tumours are mutated on KRAS, shows the direct link between RAS pathway-induced transcriptional activity and tumour aggressiveness. This evidence concerns the gene KRAS and pancreatic neoplasm.